📰 Nir Altschuler News
Nir Altschuler News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nir Altschuler. Real-time updates on events, politics, business and more.
November 22, 2023
Smith+Nephew to acquire CartiHeal, developer of Agili-C
November 22, 2023
A previous deal with US company Bioventus fell through. Israeli company CartiHeal has developed an implant for treating cartilage and joint surface lesions in the knee.
November 22, 2023
Israeli medical device company CartiHeal is getting bought out by the British medical equipment company Smith & Nephew (S&N) in a deal that could be worth as much as $330 million. $180 million will be paid now and up to another $150 million could be paid out if certain requirements are met. In 2022, CartiHeal […]
July 26, 2023
CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken Zaslav, a specialist in Orthopedic Surgery and Sports Medicine at Northwell Health in New York City, NY.
April 6, 2022
/PRNewswire/ -- Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare opportunities, today realized the USD 500...
March 30, 2022
/PRNewswire/ -- CartiHeal Ltd, developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today...
March 30, 2022
CartiHeal announced today that it received FDA premarket approval for its Agili-C implant for treating knee joint surface lesions.
March 30, 2022
US orthologics company Bioventus is acquiring the Israeli cartilage implants company for $350 million, plus $150 million from future revenue.
January 5, 2022
As part of our 20th anniversary celebration, we find out what happened to some of the most promising startups we featured in our early days.
August 4, 2021
CartiHeal succeeds in clinical trial for cartilage treatment CartiHeal is on a Breakthrough Therapy fast track for FDA approval, and US company Bioventus has an option to acquire it. Israeli company CartiHeal has announced success in a clinical trial of its treatment for knee cartilage damaged either by injury or by arthritis. The company reported that its cartilage substitute product was more successful than the currently used treatments. The trial involved 251 patients, and was conducted over...